IPO news, reviews, and company spotlights.

Doncasters’ DPC Debut Shows the IPO Window Still Pays for Aerospace Scarcity

DPC priced above range, upsized the deal, and still traded like a shortage asset

Sinda’s IPO Has the Buyers Most Exploration Deals Only Promise

Sinda brings Fresnillo, Franco-Nevada and a real bank group to a pre-revenue silver float

CopperTech's IPO Is Really a Mine-Financing Test for Vedanta

CopperTech asks IPO buyers to fund only part of Vedanta's Zambia rebuild

Lime's IPO Finally Has Terms, but the Debt Clock Is the Real Story

Lime brings real scale to market, but this IPO still has to fix the balance sheet

Kardigan Led, First Carolina Cleared, and the Rest of the Calendar Stayed on Paper

Two deals reached real trading, but most of the IPO calendar still has more filing motion than market proof

Kardigan gave the week its only unambiguous risk-on signal. The biotech priced an upsized 25 million-share IPO at $16 for $400 million...

DSC’s $51 Million IPO Hinges on a $30 Million Named Order

DSC’s small Nasdaq IPO has one order big enough to define the book

Freenome Reaches Market With a Real PIPE and a Very Thin Public Float

Freenome’s $240 million PIPE gives FRNM real backing, but the float still looks fragile

SpaceX's $85.7 Billion IPO Close Turns the Calendar Into a Stress Test

SpaceX closed the largest IPO on the board, but public investors are really underwriting a combined launch, Starlink and AI capital stack

Sunshine Silver Cleared the IPO Market, but It Still Has to Build the Mine

Sunshine Silver priced at the bottom, filled the shoe, and brought a U.S. silver-antimony restart story to market

ReserveOne’s Nasdaq Pitch Is Really a Private-Capital Test

ReserveOne reaches effectiveness with $750 million of crypto-backed commitments behind RONE

Einride Reaches Nasdaq With Real Freight-Tech Traction and a Complicated Capital Stack

Einride’s public debut brings a live freight platform, a $113 million PIPE, and heavy structural baggage

Parabilis Turned a Biotech IPO Into a Platform Financing Event

Parabilis priced above range, brought Regeneron with it, and made the market fund the platform

BSTR Brings Bitcoin Treasury Scale, and Heavy SPAC Math, to Market

BSTR heads to a June vote with 30,021 BTC promised and public holders facing a thin slice

IQM Brings Operating Proof to a Warrant-Heavy Quantum Listing

IQM pushes its PIPE above $146 million, but IQMX is still a redemption trade

Applied Aerospace & Defense Brings a Defense IPO to Market, and a Debt Story With It

AADX priced cleanly, but the real question is what public investors are refinancing

Liftoff’s IPO Reset Still Found Demand

Liftoff priced above range, but the real story is debt paydown and sponsor control

ERock’s IPO Sells AI-Era Power Speed, but the Structure Demands Caution

ERock brings a $600 million AI-power IPO to market, with real backlog and real structural caveats

WhiteHawk’s IPO Has Real Buyers. The Structure Is the Debate.

WhiteHawk’s $74 million of cornerstones puts real shape on a tricky gas-royalty IPO

Quantinuum's Upsized IPO Is a Scarcity Bet on Quantum

Quantinuum lifts its IPO again, but public buyers still get only a slice of the operating company

Weekly IPO Review: AVAT Led a Selective Week While the Bigger Calendar Mostly Tested Distribution

AVAT pushed ahead, INNIO launched, and most of late May’s heft still leaned secondary

The week of May 25 to May 31 did not broaden the IPO market so much as clarify its split. The cleanest progression came from special situations, not from a fresh run of conventional operating-company debuts. Avalanche...

Avalanche Treasury Nears Its Vote With the Redemption Math in Focus

AVAT is selling a public AVAX treasury, but the June clock and the financing structure matter more than the slogan

Bridge III Returns The Liu Playbook To Market, With Newbridge Still Running

Bridge III tests appetite for another Yongsheng Liu SPAC while Newbridge is already live

INNIO Brings AI-Power Heat to a $2 Billion Sponsor Exit

INNIO has real data-center demand, but this IPO mainly cashes out the seller

Lincoln Clears, the Rest of the Calendar Stays in Filing Mode

Lincoln broke through; the rest of the IPO week stayed in amendment mode

Lincoln International priced its IPO on May 19 (https://www.prnewswire.com/news-releases/lincoln-international-announces-pricing-of-initial-public-offering-302776889.html), and by the next day’s NYSE debut...

Lincoln International's Clean IPO Masks a Tight Control Structure

Lincoln priced at $20 and traded up, but the structure deserves more attention

Fervo's IPO turned geothermal into an AI-power proxy

Fervo priced like a scale-power winner. The filing still reads like a buildout.

Micware’s Small Nasdaq IPO Carries a Bigger SDV Bet

Micware upsized its Nasdaq IPO, but the real question is what public investors are being asked to fund

Weekly IPO Review: Cerebras and Fervo reopened the window, but selectivity stayed brutal

Cerebras and Fervo reopened the IPO window. The rest of the calendar still had to fight for it.

Cerebras and Fervo did not just price in the week of May 11 through May 17. They reset the ceiling for what the 2026 IPO market will fund. Cerebras used a May 11 S-1/A to lift its range to $150 to $160 and expand the...

Pershing Square’s $5 Billion IPO Solved the Fundraise, Not the Discount

Ackman’s dual listing gave PSUS permanent capital and left public investors sorting out the structure

Avalanche Treasury Brings an AVAX Balance Sheet to the IPO Calendar

AVAT is testing whether public investors want a listed AVAX treasury

Einride’s Market Debut Is Taking Shape, but the Structure Still Does the Talking

Einride nears Nasdaq with a real freight story and a very SPAC capital stack

EagleRock Opens the IPO Window for Permian Surface Economics

EROK’s debut shows demand for Permian land cash flow, but the public float buys a minority seat

ReserveOne Nears Nasdaq With a $750 Million Crypto Financing Package and Very Little Operating History

ReserveOne pushes toward RONE with a big PIPE, a note stack, and an unusual control map

Selective Reopening: HawkEye and Odyssey Cleared, but Structure Still Did the Work

Weekly IPO Review: selective reopening, with HawkEye and Odyssey leading

Selective reopening, not a broad one The week looked better than it felt. HawkEye 360 jumped 30% in its NYSE debut after pricing 16 million shares at $26, the top of its range...

Cerebras Is Asking IPO Buyers to Finance an AI Capacity Buildout

Cerebras' IPO is becoming a live test of how far AI demand can finance infrastructure

Biotech Took the Week. The Rest of the IPO Calendar Still Had Work to Do.

Biotech finally converted the pipeline into cash

The week of April 27 to May 3 finally turned IPO optimism into executed biotech paper. After X-Energy filed its final prospectus for a $1.02 billion IPO...

Weekly IPO Review: X-Energy Prices, Pershing Tests the Tape

X-Energy priced and popped. Pershing still set the week's agenda.

X-Energy broke the week open by doing the one thing most of the calendar still has not done: price cleanly and trade well. The company priced 44,254,659 shares at $23, above the $16 to $19 range in its April 20 S-1/A,...

IPO Week: The Large-Cap Window Reopened, Selectively

IPO week: Madison Air, Arxis and Kailera reopen the size window

The week of April 13 gave the IPO market a real size test. Madison Air, Arxis, Kailera, AEVEX and Alamar all crossed from filing work into priced offerings, raising roughly $4.5 billion before overallotments. That is...

HMH Carries a Thin IPO Week Across the Line

HMH prices; Elmet and Churchill refill the IPO queue

HMH was the week’s only real handoff from filing work to public trading. The offshore drilling equipment supplier priced 10.52 million Class A shares at $20, inside its $19 to $22 range, raised $210.4 million in gross...